CM
ABMD

Castleark Management’s Abiomed Inc ABMD Stock Holding History

Castleark Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-52,868
Closed -$9.02M – 404
2019
Q4 		$9.02M Sell
52,868
-6,010
-10% -$1.11M 0.36% 91
2019
Q3 		$10.5M Sell
58,878
-67,442
-53% -$14.6M 0.43% 74
2019
Q2 		$32.9M Buy
126,320
+31,087
+33% +$8.25M 1.26% 18
2019
Q1 		$27.2M Sell
95,233
-23,216
-20% -$7.72M 1.02% 25
2018
Q4 		$38.5M Sell
118,449
-10,210
-8% -$3.55M 1.64% 9
2018
Q3 		$57.9M Sell
128,659
-30,511
-19% -$12M 1.66% 5
2018
Q2 		$65.1M Sell
159,170
-104,054
-40% -$37.7M 2% 2
2018
Q1 		$76.6M Sell
263,224
-16,820
-6% -$4.26M 2.43% 1
2017
Q4 		$52.5M Sell
280,044
-59,917
-18% -$11.2M 1.58% 6
2017
Q3 		$57.3M Buy
339,961
+37,616
+12% +$5.69M 1.8% 2
2017
Q2 		$43.3M Buy
302,345
+78,648
+35% +$10.6M 1.42% 7
2017
Q1 		$28M Sell
223,697
-183,742
-45% -$21.3M 0.88% 28
2016
Q4 		$45.9M Buy
407,439
+45,012
+12% +$5.21M 1.46% 8
2016
Q3 		$46.6M Buy
362,427
+58,850
+19% +$7.05M 1.41% 14
2016
Q2 		$33.2M Buy
303,577
+236,920
+355% +$23.6M 1.06% 26
2016
Q1 		$6.32M Sell
66,657
-70,679
-51% -$5.97M 0.2% 136
2015
Q4 		$12.4M Sell
137,336
-37,345
-21% -$3.17M 0.37% 70
2015
Q3 		$16.2M Sell
174,681
-59,194
-25% -$5.22M 0.52% 45
2015
Q2 		$15.4M Sell
233,875
-7,375
-3% -$490K 0.41% 68
2015
Q1 		$17.3M Buy
241,250
+37,925
+19% +$2.06M 0.42% 67
2014
Q4 		$7.74M Buy
+203,325
New +$6.41M 0.2% 137

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Castleark Management's ABMD Position: Q1 2020 in Review

Castleark Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 52,868 shares — an estimated $9.02M sold.

Castleark Management first reported a position in ABMD in Q4 2014 and held it in 21 quarters. The position peaked at $76.6M in Q1 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Castleark Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Castleark Management sold 52,868 Abiomed Inc shares in Q1 2020, an estimated $9.02M.
  • Castleark Management first reported a position in Abiomed Inc in Q4 2014 and held it in 21 quarters.
  • Castleark Management's Abiomed Inc position peaked at $76.6M in Q1 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Castleark Management's 13F filing for Q1 2020, filed 13 May 2020.